FDA Inspection
Qualgen, LLCQualgen, LLC – FDA Inspection, May 10, 2017
Record Details
This FDA Inspection record concerns Qualgen, LLC, with an inspection on May 10, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d20201b1-e87c-4395-a9f4-078f8d6dd9aa
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1014041
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- 21 CFR 211.110(a)Written in-process control procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Qualgen, LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 4, 2025 | Not classified | Dallas District Office | Drug Quality Assurance |
| March 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 13, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qualgen, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.